Lung Cancer Therapy
Studies from National Taiwan Normal University, Department of Life Sciences provide new data on lung cancer therapy
Published in Oncology Business Week, September 7th, 2008
Fresh data on lung cancer are presented in the report 'Novel 2-step synthetic indole compound 1,1,3-tri(3-indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models.' According to recent research published in the journal Cancer, "The clinical responses to chemotherapy in lung cancer patients are unsatisfactory. Thus, the development of more effective anticancer drugs for lung cancer is urgently needed."
"A 2-step novel synthetic compound, referred to as 1,1,3-tri(3-indolyl)cyclohexane (3-indole), was generated in high purity and yield. 3-Indole was tested for its biologic activity in A549, H1299, H1435, CL1-1, and H1437 lung cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Advanced Cancer Therapeutics, LLC
Advanced Cancer Therapeutics Appoints Gilles Tapolsky, Ph.D. to Chief Scientific Officer - AMDL
AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140% - AMRI
AMRI Initiates Phase I Study of Proprietary Oncology Drug Candidate - Angiogenesis
Reports from Taiho Pharmaceutical Co., Ltd. add new data to research in angiogenesis - Apoptosis
AposenseŽ [18f]-ml-10 To Be Radiolabelled By Iba for Multi-center Clinical Trials - Arno Therapeutics, Inc.
Arno Therapeutics Announces Second Quarter 2008 Financial Results - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
